此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

博导风采
戴海明

发布时间:2015-07-16 来源:

                            Haiming DAI, Ph.D., Professor, graduated from Department of Biology, University of Science and Technology of China (USTC) in 1998, obtained a Bachelor degree. He joined Professor Yunyu Shi’s lab at USTC in 2001, engaging in the protein structure genomics program, and obtained a Ph.D. degree in 2006. From 2006 to 2015, Dr. Dai joined Dr. Scott Kaufmann’s lab at Mayo Clinic, studying signaling pathways of Bcl-2 family proteins and molecular mechanisms of anticancer drugs induced cell death. Dr. Dai published 26 research papers on J. Cell Biol., Cancer Res., J Biol. Chem.,etc, which have been cited more than 300 times. His publication on J. Cell Biol., 2011 has been recommended by “Faculty of 1000”. Dr. Dai joined Hefei Institutes of Physics Science, C.A.S. as a “100-talent program” candidate in 2015.   

  Research Interests 

  1.Apoptosis related protein-protein interactions and protein-lipid interactions. 

  2.Anticancer drug mechanisms and how to improve anticancer drug efficiency. 

  3.Anticancer drug development. 

  4.Molecular markers of Cancer and personalized medicine. 

  Contact Information 

  Center of Medical Physics and Technology, 

  Hefei Institutes of Physics Science, C.A.S. 

  350 Shushanhu Road, Hefei, Anhui, China, 230031 

  Tel: 0551-62727063 

  E-mail: daih@cmpt.ac.cn 

个人介绍

  戴海明,男,40岁,博士,研究员,博士研究生导师。1998年在中国科学技术大学生物系获得学士学位,2001-2006年师从中国科大施蕴渝院士进行蛋白质结构基因组研究,获得博士学位。2006-2015年,在美国梅奥医学院从事细胞凋亡分子机制、抗肿瘤药物作用机制等方面研究。 J. Cell Biol., Cancer Res., J Biol. Chem.等杂志上发表论文26篇(其中第一作者或者通讯作者9篇),论文被他引300余次。其中2011年发表在J. Cell Biol.论文被Faculty of 1000 收录并给予高度评价。2015年中科院“百人计划”候选人,任医学物理与技术中心分子病理学研究室主任。        

  研究领域: 

  1.细胞凋亡相关的蛋白质相互作用研究,蛋白质与脂分子的相互作用研究。 

  2.抗肿瘤药物作用机制及多药联用提高抗肿瘤药物疗效研究。 

  3.抗肿瘤药物的研发。 

  4.肿瘤的分子标志物以及靶向治疗研究。 

  联系方式: 

  地址:合肥市蜀山湖路350号医学物理与技术中心,邮编 230031 

  电话: 0551-62727063 

  电子信箱: daih@cmpt.ac.cn